International Conferences

Recommended Conferences for Proton Pump Inhibitor

Proton Pump Inhibitor

There are 11 National symposiums are related to Proton pump inhibitors which are hosed by OMICS International

Proton pump inhibitors plays important role in Gastroesophageal Reflux Disease (GERD) by reducing the production of acid by blocking the enzyme in the wall of the stomach that produces acid. The reduction of acid prevents ulcers and allows any ulcers that exist in the esophagus, stomach, and duodenum to heal. They are called 'proton pump inhibitors' because they work by blocking (inhibiting) a chemical system called the hydrogen-potassium adenosine triphosphatase enzyme system (otherwise known as the 'proton pump'). This chemical system is found in the cells in the stomach lining that make stomach acid.
Stomach normally produces acid to help with the digestion of food and to kill bacteria. This acid is corrosive so your body produces a natural mucous barrier which protects the lining of the stomach from being eroded. Proton pump inhibitors (PPIs) are a class (group) of drugs that work on the cells that line the stomach, reducing the production of acid. They include: esomeprazole, lansoprazole, omeprazole, pantoprazole and rabeprazole, and come in various different brand names.

In some people this barrier may have broken down allowing the acid to damage the stomach, causing an ulcer. In others there may be a problem with the muscular band at the top of the stomach (the sphincter) that keeps the stomach tightly closed. This may allow the acid to escape and irritate the oesophagus (gullet). This is called 'acid reflux' which can cause heartburn and/or oesophagitis. PPIs stop cells in the lining of the stomach producing too much acid. This can help to prevent ulcers from forming or assist the healing process. By decreasing the amount of acid, they can also help to reduce acid reflux-related symptoms such as heartburn.

Proton pump inhibitors act by irreversibly blocking the hydrogen/potassium adenosine triphosphatase enzyme system (the H+/K+ ATPase, or, more commonly, the gastric proton pump) of the gastric parietal cells. The proton pump is the terminal stage in gastric acid secretion, being directly responsible for secreting H+ ions into the gastric lumen, making it an ideal target for inhibiting acid secretion.

Scope and Importance

Proton-pump inhibitors (PPIs) are a group of drugs whose main action is a pronounced and long-lasting reduction of gastric acid production. They are the most potent inhibitors of acid secretion available. In general, proton pump inhibitors are well tolerated, and the incidence of short-term adverse effects is relatively low. Long-term use of PPIs has been less studied than short-term use, and the lack of data makes it difficult to make definitive statements.

Market Analysis

This statistic displays the market share of the top ten proton pump inhibitors based on total US prescriptions in 2013. In that year, Nexium was among the leading proton pump inhibitors with a total market share of 15.4 percent of prescriptions in the United States. Proton pump inhibitors are drugs that aid in the long-term reduction of gastric acid production. It is often used to treat conditions such as peptic ulcer disease and Barrett's esophagus.

OMICS International organises 1000+ Global Events every year in Conference series, on Clinical, Medicine, Pharma and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 700+ open access journals  which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members.

List of Best International Conferences

1. Nucleic Acids Conference
   August 04-06, 2016 Seattle, USA
    
2. Synthetic Biology Conference
   September 28-30, 2015 Houston, USA
    
3. Protein Engineering Conference
   October 26-28, 2015 Chicago, USA
    
4. Clinical and Molecular Genetics Conference
   November 28-30, 2016 Chicago, USA
    
5. 2^nd Transcriptomics Conference
   August 15-17, 2016 Portland, USA
    
6. 3^rd Genomics & Pharmacogenomics Conference
   September 21-23, 2015 San Antonio, USA
    
7. 3^rd Clinical Pharmacy Conference
   December 07-09, 2015 Atlanta, USA
    
8. 4^th Integrative Biology Conference
   June 13-15, 2016 Berlin, Germany
    
9. 4^th Clinical Microbiology & Microbial Genomics Conference
   October 05-07, 2015 Philadelphia, USA
    
10. 5^th Computational Systems Biology Conference
    August 22-23, 2016 Philadelphia, USA
     
11. 5^th Metabolomics Conference
    May 16-18, 2016 Osaka, Japan
     
12. 6^th Metabolomics Conference
    November 28-30, 2016 Chicago, USA 
     
13. 6^th Proteomics Conference
    March 29-30, 2016 Atlanta, USA
     
14. 6^th Bioinformatics Conference
    March 29-30, 2016 Valencia, Spain
     
15. 7^th Proteomics Conference
    October 10-12, 2016 Rome, Italy

Relevant Societies and Associations

1. International Proteolysis Society
2. Human Proteome Organization
3. International Society for Computational Biology
4. Association for Mass Spectrometry Applications to the Clinical Lab (MSACL Inc.)
5. Indian Society of Mass Spectrometry(ISMAS)
6. Chinese Mass Spectrometry Society(CMSS)
7. European Proteomics Association
8. Italian Proteomic Association
9. Norwegian Proteomic Society
10. Spanish Proteomics Society

Companies:

1. Domainex
2. Indus Pharma (Pvt.) Ltd.
3. ILYANG pharmaceutical Co., Ltd.
4. Medsafe
5. Cultek
6. Integromics
7. NuSep
8. Promega
9. AB SCIEX
10. Enanta Pharmaceuticals
11. InsightPharma
12. Enzo Life Sciences
13. Sigma-Aldaich
14. A.G. Scientific. Inc.
15. Ambipro Inc.
16. American Bioanalytical
17. Amersham Pharmacia Biotech
18. AMS Biotechnology

This page will be updated regularly.

This page was last updated on April 26, 2024